auxillium

  1. Nelson Vergel

    Auxillium, makers of Testim, Sales Decline After Negative Testosterone Press

    In the first quarter of 2014, the Company expects to record worldwide Testim revenues of approximately $11 to 13 million, compared to $45.5 million in the first quarter of 2013; full-year Testim sales for 2014 are now expected to be less than $85 million. The Company is continuing to finalize...
Back
Top